Genetic Analysis of Right Heart Structure and Function in 40,000 People

Total Page:16

File Type:pdf, Size:1020Kb

Load more

bioRxiv preprint doi: https://doi.org/10.1101/2021.02.05.429046; this version posted February 6, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Genetic Analysis of Right Heart Structure and Function in 40,000 People James P. Pirruccello*1,2,3,4, Paolo Di Achille*3,5, Victor Nauffal*3,6, Mahan Nekoui3,4, Samuel N. Friedman3,5, Marcus D. R. Klarqvist3,5, Mark D. Chaffin3, Shaan Khurshid1,2,3, Carolina Roselli3,7, Puneet Batra5, Kenney Ng8, Steven A. Lubitz1,2,3,4, Jennifer E. Ho1,2,4, Mark E. Lindsay1,2,3,4,9, Anthony A. Philippakis5,10, Patrick T. Ellinor1,2,3,4 1 Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts, USA 2 Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA 3 Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA 4 Harvard Medical School, Boston, Massachusetts, USA 5 Data Sciences Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA 6 Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA 7 University Medical Center Groningen, University of Groningen, Groningen, NL 8 IBM Research, Cambridge, Massachusetts, USA 9 Thoracic Aortic Center, Massachusetts General Hospital, Boston, Massachusetts, USA 10 GV, Mountain View, California, USA * = These authors contributed equally to this work. Running Title: Genetics of the right heart Keywords: Right ventricle, right atrium, pulmonary artery, deep learning, Poisson surface reconstruction, cardiovascular disease, genetics Corresponding Author: Patrick T. Ellinor, MD, PhD Cardiovascular Disease Initiative The Broad Institute of MIT and Harvard 75 Ames Street Cambridge, MA 02142 [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2021.02.05.429046; this version posted February 6, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The heart evolved hundreds of millions of years ago. During mammalian evolution, the cardiovascular system developed with complete separation between pulmonary and systemic circulations incorporated into a single pump with chambers dedicated to each circulation. A lower pressure right heart chamber supplies deoxygenated blood to the lungs, while a high pressure left heart chamber supplies oxygenated blood to the rest of the body. Due to the complexity of morphogenic cardiac looping and septation required to form these two chambers, congenital heart diseases often involve maldevelopment of the evolutionarily recent right heart chamber. Additionally, some diseases predominantly affect structures of the right heart, including arrhythmogenic right ventricular cardiomyopathy (ARVC) and pulmonary hypertension. To gain insight into right heart structure and function, we fine-tuned deep learning models to recognize the right atrium, the right ventricle, and the pulmonary artery, and then used those models to measure right heart structures in over 40,000 individuals from the UK Biobank with magnetic resonance imaging. We found associations between these measurements and clinical disease including pulmonary hypertension and dilated cardiomyopathy. We then conducted genome-wide association studies, identifying 104 distinct loci associated with at least one right heart measurement. Several of these loci were found near genes previously linked with congenital heart disease, such as NKX2-5, TBX3, WNT9B, and GATA4. We also observed interesting commonalities and differences in association patterns at genetic loci linked with both right and left ventricular measurements. Finally, we found that a polygenic predictor of right ventricular end systolic volume was associated with incident dilated cardiomyopathy (HR 1.28 per standard deviation; P = 2.4E-10), and remained a significant predictor of disease even after accounting for a left ventricular polygenic score. Harnessing deep learning to perform large-scale cardiac phenotyping, our results yield insights into the genetic and clinical determinants of right heart structure and function. bioRxiv preprint doi: https://doi.org/10.1101/2021.02.05.429046; this version posted February 6, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The heart evolved hundreds of millions of years ago as a tubular organ1. Septation of the main pumping chamber of the heart into distinct left and right ventricles evolved later in birds, mammals, and some reptiles, and is under the control of conserved transcription factors such as TBX52. Substantially greater delivery of oxygen to the systemic circulation—and to the heart itself—is the putative advantage of this separation of the circulatory system into a left heart- driven systemic circuit and a right heart-driven pulmonary circuit3. The structures of the left and right heart are derived from different progenitor cell populations and operate under different pressure regimes: the left heart operates against high pressure, while the right heart generally faces little afterload. During embryogenesis, the left ventricle forms from the first heart field, while the right ventricle, the outflow tract, and portions of the atria form from the second heart field4–7. Septation of the outflow tract also requires neuroectodermal neural crest cells8–10. The distinct embryological origins of the right and left ventricles likely explain, in part, the existence of right heart-predominant pathologies. These include arrhythmogenic right ventricular cardiomyopathy (ARVC)11–14, Brugada syndrome, and pulmonary hypertension. In addition, right ventricular dysfunction can play a role in other heart failure syndromes. The function of the right heart is an important determinant of outcomes in people who have heart failure with either reduced (HFrEF) or preserved left ventricular ejection fraction (HFpEF)15–17. HFpEF represents a heterogeneous set of diseases for which very few disease-modifying therapies exist. Consequently, there is substantial interest in identifying new therapies for conditions such as right ventricular dysfunction18–21. The distinct pathologies, embryology, and physiology of the right heart motivated our efforts to quantify right heart structure and function, and to probe the common genetic basis for human variation in these measurements. bioRxiv preprint doi: https://doi.org/10.1101/2021.02.05.429046; this version posted February 6, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Results In this work, we developed deep learning models to determine the dimensions and function of the right atrium (RA), the right ventricle (RV), and the pulmonary artery (PA) in up to 45,000 UK Biobank participants. We then evaluated the epidemiologic associations, pathologic outcomes, and the common genetic basis of variation in these right heart structures. Reconstruction of right heart structures from cardiovascular magnetic resonance images We first derived right heart measurements in the UK Biobank imaging substudy of over 45,000 people22–24 using deep learning models. To do so, a cardiologist created training data for deep learning models by manually tracing the right atrium and right ventricle in the four-chamber long axis view, and the right ventricle and pulmonary artery in the short axis view (Figure 1). This process, called semantic segmentation, yielded anatomical labels identifying the pixels belonging to cardiac structures in 714 short axis images and 445 four-chamber long axis images. Two U-Net derived deep learning models, containing long-range skip connections that allow for pixel-accurate segmentation, were then trained from these data: one for the four- chamber long axis view and another for the short axis views25,26. The deep learning models were then used to produce pixel labels for the remainder of the images. Quality assessment is detailed in the Online Methods and Supplementary Note. The deep learning model output was then post-processed to extract measurements of the right atrium, the right ventricle, and the pulmonary artery. The right atrium was only consistently visible in one view (the four-chamber long axis view), and therefore a 2-dimensional area was computed by summing the pixels and multiplying by their width and height. We computed the maximum and minimum area during the cardiac cycle, as well as the fractional area change (RA FAC), which is the ratio of the change in area between the maximum and minimum area divided by the maximum area. The right ventricle has a complex 3-dimensional geometry; to estimate right ventricular structure, we integrated data from the short axis views and the four-chamber long axis view with a Poisson surface reconstruction approach, detailed in the Online Methods. We measured the maximum volume (right ventricular end diastolic volume; RVEDV), the minimum volume (right ventricular end systolic volume; RVESV), the difference between those two volumes (stroke volume), and the ejection fraction (RVEF). The pulmonary trunk’s elliptical minor axis (diameter) was computed from short axis images at end-systole. For participants whose pulmonary trunk was visible in multiple short-axis slices, we refer to the component closest
Recommended publications
  • The Connections of Wnt Pathway Components with Cell Cycle and Centrosome: Side Effects Or a Hidden Logic?

    The Connections of Wnt Pathway Components with Cell Cycle and Centrosome: Side Effects Or a Hidden Logic?

    Critical Reviews in Biochemistry and Molecular Biology ISSN: 1040-9238 (Print) 1549-7798 (Online) Journal homepage: http://www.tandfonline.com/loi/ibmg20 The connections of Wnt pathway components with cell cycle and centrosome: side effects or a hidden logic? Vítězslav Bryja , Igor Červenka & Lukáš Čajánek To cite this article: Vítězslav Bryja , Igor Červenka & Lukáš Čajánek (2017): The connections of Wnt pathway components with cell cycle and centrosome: side effects or a hidden logic?, Critical Reviews in Biochemistry and Molecular Biology, DOI: 10.1080/10409238.2017.1350135 To link to this article: http://dx.doi.org/10.1080/10409238.2017.1350135 Published online: 25 Jul 2017. Submit your article to this journal Article views: 72 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=ibmg20 Download by: [Masarykova Univerzita v Brne], [Lukas Cajanek] Date: 08 August 2017, At: 01:58 CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017 https://doi.org/10.1080/10409238.2017.1350135 REVIEW ARTICLE The connections of Wnt pathway components with cell cycle and centrosome: side effects or a hidden logic? Vıtezslav Bryjaa , Igor Cervenka b and Lukas Caj anekc aDepartment of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic; bMolecular and Cellular Exercise Physiology, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden; cDepartment of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic ABSTRACT ARTICLE HISTORY Wnt signaling cascade has developed together with multicellularity to orchestrate the develop- Received 10 April 2017 ment and homeostasis of complex structures.
  • Next Generation Sequencing Panels for Disorders of Sex Development

    Next Generation Sequencing Panels for Disorders of Sex Development

    Next Generation Sequencing Panels for Disorders of Sex Development Disorders of Sex Development – Overview Disorders of sex development (DSDs) occur when sex development does not follow the course of typical male or female patterning. Types of DSDs include congenital development of ambiguous genitalia, disjunction between the internal and external sex anatomy, incomplete development of the sex anatomy, and abnormalities of the development of gonads (such as ovotestes or streak ovaries) (1). Sex chromosome anomalies including Turner syndrome and Klinefelter syndrome as well as sex chromosome mosaicism are also considered to be DSDs. DSDs can be caused by a wide range of genetic abnormalities (2). Determining the etiology of a patient’s DSD can assist in deciding gender assignment, provide recurrence risk information for future pregnancies, and can identify potential health problems such as adrenal crisis or gonadoblastoma (1, 3). Sex chromosome aneuploidy and copy number variation are common genetic causes of DSDs. For this reason, chromosome analysis and/or microarray analysis typically should be the first genetic analysis in the case of a patient with ambiguous genitalia or other suspected disorder of sex development. Identifying whether a patient has a 46,XY or 46,XX karyotype can also be helpful in determining appropriate additional genetic testing. Abnormal/Ambiguous Genitalia Panel Our Abnormal/Ambiguous Genitalia Panel includes mutation analysis of 72 genes associated with both syndromic and non-syndromic DSDs. This comprehensive panel evaluates a broad range of genetic causes of ambiguous or abnormal genitalia, including conditions in which abnormal genitalia are the primary physical finding as well as syndromic conditions that involve abnormal genitalia in addition to other congenital anomalies.
  • Identification of the Binding Partners for Hspb2 and Cryab Reveals

    Identification of the Binding Partners for Hspb2 and Cryab Reveals

    Brigham Young University BYU ScholarsArchive Theses and Dissertations 2013-12-12 Identification of the Binding arP tners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non- Redundant Roles for Small Heat Shock Proteins Kelsey Murphey Langston Brigham Young University - Provo Follow this and additional works at: https://scholarsarchive.byu.edu/etd Part of the Microbiology Commons BYU ScholarsArchive Citation Langston, Kelsey Murphey, "Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins" (2013). Theses and Dissertations. 3822. https://scholarsarchive.byu.edu/etd/3822 This Thesis is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please contact [email protected], [email protected]. Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston A thesis submitted to the faculty of Brigham Young University in partial fulfillment of the requirements for the degree of Master of Science Julianne H. Grose, Chair William R. McCleary Brian Poole Department of Microbiology and Molecular Biology Brigham Young University December 2013 Copyright © 2013 Kelsey Langston All Rights Reserved ABSTRACT Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactors and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston Department of Microbiology and Molecular Biology, BYU Master of Science Small Heat Shock Proteins (sHSP) are molecular chaperones that play protective roles in cell survival and have been shown to possess chaperone activity.
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
  • Atherosclerosis-Susceptible and Atherosclerosis-Resistant Pigeon Aortic Cells Express Different Genes in Vivo

    Atherosclerosis-Susceptible and Atherosclerosis-Resistant Pigeon Aortic Cells Express Different Genes in Vivo

    University of New Hampshire University of New Hampshire Scholars' Repository New Hampshire Agricultural Experiment Station Publications New Hampshire Agricultural Experiment Station 7-1-2013 Atherosclerosis-susceptible and atherosclerosis-resistant pigeon aortic cells express different genes in vivo Janet L. Anderson University of New Hampshire, [email protected] C. M. Ashwell University of New Hampshire - Main Campus S. C. Smith University of New Hampshire - Main Campus R. Shine University of New Hampshire - Main Campus E. C. Smith University of New Hampshire - Main Campus See next page for additional authors Follow this and additional works at: https://scholars.unh.edu/nhaes Part of the Poultry or Avian Science Commons Recommended Citation J. L. Anderson, C. M. Ashwell, S. C. Smith, R. Shine, E. C. Smith and R. L. Taylor, Jr. Atherosclerosis- susceptible and atherosclerosis-resistant pigeon aortic cells express different genes in vivo Poultry Science (2013) 92 (10): 2668-2680 doi:10.3382/ps.2013-03306 This Article is brought to you for free and open access by the New Hampshire Agricultural Experiment Station at University of New Hampshire Scholars' Repository. It has been accepted for inclusion in New Hampshire Agricultural Experiment Station Publications by an authorized administrator of University of New Hampshire Scholars' Repository. For more information, please contact [email protected]. Authors Janet L. Anderson, C. M. Ashwell, S. C. Smith, R. Shine, E. C. Smith, and Robert L. Taylor Jr. This article is available at University of New Hampshire Scholars' Repository: https://scholars.unh.edu/nhaes/207 Atherosclerosis-susceptible and atherosclerosis-resistant pigeon aortic cells express different genes in vivo J.
  • Cldn19 Clic2 Clmp Cln3

    Cldn19 Clic2 Clmp Cln3

    NewbornDx™ Advanced Sequencing Evaluation When time to diagnosis matters, the NewbornDx™ Advanced Sequencing Evaluation from Athena Diagnostics delivers rapid, 5- to 7-day results on a targeted 1,722-genes. A2ML1 ALAD ATM CAV1 CLDN19 CTNS DOCK7 ETFB FOXC2 GLUL HOXC13 JAK3 AAAS ALAS2 ATP1A2 CBL CLIC2 CTRC DOCK8 ETFDH FOXE1 GLYCTK HOXD13 JUP AARS2 ALDH18A1 ATP1A3 CBS CLMP CTSA DOK7 ETHE1 FOXE3 GM2A HPD KANK1 AASS ALDH1A2 ATP2B3 CC2D2A CLN3 CTSD DOLK EVC FOXF1 GMPPA HPGD K ANSL1 ABAT ALDH3A2 ATP5A1 CCDC103 CLN5 CTSK DPAGT1 EVC2 FOXG1 GMPPB HPRT1 KAT6B ABCA12 ALDH4A1 ATP5E CCDC114 CLN6 CUBN DPM1 EXOC4 FOXH1 GNA11 HPSE2 KCNA2 ABCA3 ALDH5A1 ATP6AP2 CCDC151 CLN8 CUL4B DPM2 EXOSC3 FOXI1 GNAI3 HRAS KCNB1 ABCA4 ALDH7A1 ATP6V0A2 CCDC22 CLP1 CUL7 DPM3 EXPH5 FOXL2 GNAO1 HSD17B10 KCND2 ABCB11 ALDOA ATP6V1B1 CCDC39 CLPB CXCR4 DPP6 EYA1 FOXP1 GNAS HSD17B4 KCNE1 ABCB4 ALDOB ATP7A CCDC40 CLPP CYB5R3 DPYD EZH2 FOXP2 GNE HSD3B2 KCNE2 ABCB6 ALG1 ATP8A2 CCDC65 CNNM2 CYC1 DPYS F10 FOXP3 GNMT HSD3B7 KCNH2 ABCB7 ALG11 ATP8B1 CCDC78 CNTN1 CYP11B1 DRC1 F11 FOXRED1 GNPAT HSPD1 KCNH5 ABCC2 ALG12 ATPAF2 CCDC8 CNTNAP1 CYP11B2 DSC2 F13A1 FRAS1 GNPTAB HSPG2 KCNJ10 ABCC8 ALG13 ATR CCDC88C CNTNAP2 CYP17A1 DSG1 F13B FREM1 GNPTG HUWE1 KCNJ11 ABCC9 ALG14 ATRX CCND2 COA5 CYP1B1 DSP F2 FREM2 GNS HYDIN KCNJ13 ABCD3 ALG2 AUH CCNO COG1 CYP24A1 DST F5 FRMD7 GORAB HYLS1 KCNJ2 ABCD4 ALG3 B3GALNT2 CCS COG4 CYP26C1 DSTYK F7 FTCD GP1BA IBA57 KCNJ5 ABHD5 ALG6 B3GAT3 CCT5 COG5 CYP27A1 DTNA F8 FTO GP1BB ICK KCNJ8 ACAD8 ALG8 B3GLCT CD151 COG6 CYP27B1 DUOX2 F9 FUCA1 GP6 ICOS KCNK3 ACAD9 ALG9
  • High Diagnostic Yield in Skeletal Ciliopathies Using Massively Parallel Genome Sequencing, Structural Variant Screening and RNA Analyses

    High Diagnostic Yield in Skeletal Ciliopathies Using Massively Parallel Genome Sequencing, Structural Variant Screening and RNA Analyses

    Journal of Human Genetics (2021) 66:995–1008 https://doi.org/10.1038/s10038-021-00925-x ARTICLE High diagnostic yield in skeletal ciliopathies using massively parallel genome sequencing, structural variant screening and RNA analyses 1 1 2,3 4 1 Anna Hammarsjö ● Maria Pettersson ● David Chitayat ● Atsuhiko Handa ● Britt-Marie Anderlid ● 5 6 7 8 9 Marco Bartocci ● Donald Basel ● Dominyka Batkovskyte ● Ana Beleza-Meireles ● Peter Conner ● 10 11 12,13 7,14 15 Jesper Eisfeldt ● Katta M. Girisha ● Brian Hon-Yin Chung ● Eva Horemuzova ● Hironobu Hyodo ● 16 1 17 18,19 20 Liene Korņejeva ● Kristina Lagerstedt-Robinson ● Angela E. Lin ● Måns Magnusson ● Shahida Moosa ● 11 10 21 15 18,22 Shalini S. Nayak ● Daniel Nilsson ● Hirofumi Ohashi ● Naoko Ohashi-Fukuda ● Henrik Stranneheim ● 1 23 24 19,22 1 7,25 Fulya Taylan ● Rasa Traberg ● Ulrika Voss ● Valtteri Wirta ● Ann Nordgren ● Gen Nishimura ● 1 1 Anna Lindstrand ● Giedre Grigelioniene Received: 4 December 2020 / Revised: 31 March 2021 / Accepted: 31 March 2021 / Published online: 20 April 2021 © The Author(s) 2021. This article is published with open access Abstract Skeletal ciliopathies are a heterogenous group of disorders with overlapping clinical and radiographic features including 1234567890();,: 1234567890();,: bone dysplasia and internal abnormalities. To date, pathogenic variants in at least 30 genes, coding for different structural cilia proteins, are reported to cause skeletal ciliopathies. Here, we summarize genetic and phenotypic features of 34 affected individuals from 29 families with skeletal ciliopathies. Molecular diagnostic testing was performed using massively parallel sequencing (MPS) in combination with copy number variant (CNV) analyses and in silico filtering for variants in known skeletal ciliopathy genes.
  • WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T

    WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T

    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T (51) International Patent Classification: David [US/US]; 13539 N . 95th Way, Scottsdale, AZ C12Q 1/68 (2006.01) 85260 (US). (21) International Application Number: (74) Agent: AKHAVAN, Ramin; Caris Science, Inc., 6655 N . PCT/US20 12/0425 19 Macarthur Blvd., Irving, TX 75039 (US). (22) International Filing Date: (81) Designated States (unless otherwise indicated, for every 14 June 2012 (14.06.2012) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, English (25) Filing Language: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, Publication Language: English DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, (30) Priority Data: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 61/497,895 16 June 201 1 (16.06.201 1) US MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, 61/499,138 20 June 201 1 (20.06.201 1) US OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, 61/501,680 27 June 201 1 (27.06.201 1) u s SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, 61/506,019 8 July 201 1(08.07.201 1) u s TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
  • Supplementary Table 1

    Supplementary Table 1

    Supplementary Table 1. 492 genes are unique to 0 h post-heat timepoint. The name, p-value, fold change, location and family of each gene are indicated. Genes were filtered for an absolute value log2 ration 1.5 and a significance value of p ≤ 0.05. Symbol p-value Log Gene Name Location Family Ratio ABCA13 1.87E-02 3.292 ATP-binding cassette, sub-family unknown transporter A (ABC1), member 13 ABCB1 1.93E-02 −1.819 ATP-binding cassette, sub-family Plasma transporter B (MDR/TAP), member 1 Membrane ABCC3 2.83E-02 2.016 ATP-binding cassette, sub-family Plasma transporter C (CFTR/MRP), member 3 Membrane ABHD6 7.79E-03 −2.717 abhydrolase domain containing 6 Cytoplasm enzyme ACAT1 4.10E-02 3.009 acetyl-CoA acetyltransferase 1 Cytoplasm enzyme ACBD4 2.66E-03 1.722 acyl-CoA binding domain unknown other containing 4 ACSL5 1.86E-02 −2.876 acyl-CoA synthetase long-chain Cytoplasm enzyme family member 5 ADAM23 3.33E-02 −3.008 ADAM metallopeptidase domain Plasma peptidase 23 Membrane ADAM29 5.58E-03 3.463 ADAM metallopeptidase domain Plasma peptidase 29 Membrane ADAMTS17 2.67E-04 3.051 ADAM metallopeptidase with Extracellular other thrombospondin type 1 motif, 17 Space ADCYAP1R1 1.20E-02 1.848 adenylate cyclase activating Plasma G-protein polypeptide 1 (pituitary) receptor Membrane coupled type I receptor ADH6 (includes 4.02E-02 −1.845 alcohol dehydrogenase 6 (class Cytoplasm enzyme EG:130) V) AHSA2 1.54E-04 −1.6 AHA1, activator of heat shock unknown other 90kDa protein ATPase homolog 2 (yeast) AK5 3.32E-02 1.658 adenylate kinase 5 Cytoplasm kinase AK7
  • RNA-Based Detection of Gene Fusions in Formalin- Fixed And

    RNA-Based Detection of Gene Fusions in Formalin- Fixed And

    Supplementary Materials RNA-Based Detection of Gene Fusions in Formalin- Fixed and Paraffin-Embedded Solid Cancer Samples Martina Kirchner, Olaf Neumann, Anna-Lena Volckmar, Fabian Stögbauer, Michael Allgäuer, Daniel Kazdal, Jan Budczies, Eugen Rempel, Regine Brandt, Suranand Babu Talla, Moritz von Winterfeld, Jonas Leichsenring, Tilmann Bochtler, Alwin Krämer, Christoph Springfeld, Peter Schirmacher, Roland Penzel, Volker Endris and Albrecht Stenzinger Table S1. PCR Primers for gene fusions identified with either the OCAv3- or Archer-panel. Amplicon Fusion Primer Seq Primer Seq [bp] AXL::CAPN15 AXL F CATGGATGAGGGTGGAGGTT CAPN15 R CTGGGCACACGTGAATCAC 178 (A19C2) BRD3::NUTM1 BRD3 F AAGAAACAGGCAGCCAAGTC NUTM1 R CTGGTGGGTCAGAAGTTGGT 217 (B11N2) ESR1-CCDC170 CCDC170 ESR1 F GGAGACTCGCTACTGTGCA CCCAGACTCCTTTCCCAACT 167 (E2C7) R ESR1-QKI (E2Q5) ESR1 F GGAGACTCGCTACTGTGCA QKI R GGCTGGTGATTTAATGTTGGC 197 ETV6::NTRK3 (E5N15) ETV6 F AAGCCCATCAACCTCTCTCA NTRK3 R GGGCTGAGGTTGTAGCACTC 206 FGFR2::INA (F17I2) FGFR2 F CTCCCAGAGACCAACGTTCA INA R GTCCTGGTATTCCCGAAAGGT 148 FNDC3B-PIK3CA PIK3CA FNDC3B F GCAGCTCAGCAGGTTATTCT GTCGTGGAGGCATTGTTCTG 177 (F3P2) R1 GATM::RAF1 (G2R8) GATM F CTTACAACGAATGGGACCCC RAF1 R GTTGGGCTCAGATTGTTGGG 160 GPBP1L1::MAST2 GPBP1L1 CGTAGTGGAGGTGGCACA MAST2 R1 AGGTGATGTGCTAGAGGTCA 178 (G6M4) F1 HNRNPA2B1::ETV1 HNRNPA GGAGGATATGGTGGTGGAGG ETV1 R TTGATTTTCAGTGGCAGGCC 164 (H9E6) 2B1 F TGATGAATCTGGAATTGTTGCT MYB::NFIB (M12N9) MYB12 F NFIB9 R CGTAATTTTGGACATTGGCCG 150 G MYB::NFIB (M13N9) MYB13 F TCTTCTGCTCACACCACTGG NFIB9 R CGTAATTTTGGACATTGGCCG 160 SND1::BRAF (S9B9) SND1 F CGATTCACCTGTCCAGCATC BRAF R CGCTGAGGTCCTGGAGATTT 184 TBL1XR1::PIK3CA TBL1XR1 F TTTCCTTGTGCCTCCATTCC PIK3CA R GTCGTGGAGGCATTGTTCTG 195 (T1P2) TMPRSS2 TMPRSS2::ERG (T2E4) CGCGGCAGGTCATATTGAA ERG R CCTTCCCATCGATGTTCTGG 190 F WHSC1L1::FGFR1 WHSC1L1 TGATCGCACTGACACGGC FGFR1 R ACAAGGCTCCACATCTCCAT 108 (W1F2) F Table S2. Clinical and diagnostic implications of the detected gene fusions. Reclassification Entities Where Entity Where Fusion Is Based on Molecular Fusion Is Fusion Drug Ref.
  • Genetic and Genomics Laboratory Tools and Approaches

    Genetic and Genomics Laboratory Tools and Approaches

    Genetic and Genomics Laboratory Tools and Approaches Meredith Yeager, PhD Cancer Genomics Research Laboratory Division of Cancer Epidemiology and Genetics [email protected] DCEG Radiation Epidemiology and Dosimetry Course 2019 www.dceg.cancer.gov/RadEpiCourse (Recent) history of genetics 2 Sequencing of the Human Genome Science 291, 1304-1351 (2001) 3 The Human Genome – 2019 • ~3.3 billion bases (A, C, G, T) • ~20,000 protein-coding genes, many non-coding RNAs (~2% of the genome) • Annotation ongoing – the initial sequencing in 2001 is still being refined, assembled and annotated, even now – hg38 • Variation (polymorphism) present within humans – Population-specific – Cosmopolitan 4 Types of polymorphisms . Single nucleotide polymorphisms (SNPs) . Common SNPs are defined as > 5% in at least one population . Abundant in genome (~50 million and counting) ATGGAACGA(G/C)AGGATA(T/A)TACGCACTATGAAG(C/A)CGGTGAGAGG . Repeats of DNA (long, short, complex, simple), insertions/deletions . A small fraction of SNPs and other types of variation are very or slightly deleterious and may contribute by themselves or with other genetic or environmental factors to a phenotype or disease 5 Different mutation rates at the nucleotide level Mutation type Mutation rate (per generation) Transition on a CpG 1.6X10-7 Transversion on a CpG 4.4X10-8 Transition: purine to purine Transition out of CpG 1.2X10-8 Transversion: purine to pyrimidine Transversion out of CpG 5.5X10-9 Substitution (average) 2.3X10-8 A and G are purines Insertion/deletion (average) 2.3X10-9 C and T are pyrimidines Mutation rate (average) 2.4X10-8 . Size of haploid genome : 3.3X109 nucleotides .
  • DYNC2H1 Gene Dynein Cytoplasmic 2 Heavy Chain 1

    DYNC2H1 Gene Dynein Cytoplasmic 2 Heavy Chain 1

    DYNC2H1 gene dynein cytoplasmic 2 heavy chain 1 Normal Function The DYNC2H1 gene provides instructions for making a protein that is part of a group ( complex) of proteins called dynein-2. The dynein-2 complex is found in cell structures known as cilia. Cilia are microscopic, finger-like projections that stick out from the surface of cells. Dynein-2 is involved in a process called intraflagellar transport (IFT), by which materials are carried within cilia. Specifically, dynein-2 is a motor that uses energy from the molecule ATP to power the transport of materials from the tip of cilia to the base. IFT is essential for the assembly and maintenance of cilia. These cell structures play central roles in many different chemical signaling pathways, including a series of reactions called the Sonic Hedgehog pathway. These pathways are important for the growth and division (proliferation) and maturation (differentiation) of cells. In particular, Sonic Hedgehog appears to be essential for the proliferation and differentiation of cells that ultimately give rise to cartilage and bone. Health Conditions Related to Genetic Changes Asphyxiating thoracic dystrophy More than 50 mutations in the DYNC2H1 gene have been identified in people with asphyxiating thoracic dystrophy, an inherited disorder of bone growth characterized by a small chest, short ribs, and shortened bones in the arms and legs. Mutations in this gene account for up to half of all cases of this condition. Most of the known mutations change single protein building blocks (amino acids) in the DYNC2H1 protein. The dynein-2 complex made with the altered protein cannot function normally, which disrupts IFT from the tip of cilia to the base and causes a buildup of materials at the tip.